All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...840Next →

hiv & aids news selected from other sources

  • Global health initiatives
    UNAIDS welcomes increase in funding from the Netherlands
    UNAIDS | 11 hours ago

    UNAIDS welcomes the decision by its third largest donor, the Netherlands, to increase its funding to UNAIDS by more than 20%. The Netherlands will provide US$ 23.3 million in core funding in 2018, compared to US$ 19.2 million in 2017.  

  • The search for a cure
    Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial
    Science Daily | 13 hours ago

    Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously treated with antiretroviral therapy (ART). The study appears September 21st in the journal Molecular Therapy.

  • Epidemiology
    US: HIV Diagnoses Up Among Younger MSM
    Medpage Today | 13 hours ago

    From 2008 to 2016, the annual number of diagnoses of HIV infection among MSM ages 13-29 increased 3%, but declined 4% among ages 30-49, and remained stable for MSM ages ≥50, reported Andrew Mitsch, MPH, of the CDC, and colleagues.

  • Health services and systems
    More Than 25% of HIV Providers Don't Know If Their State Expanded Medicaid
    American Journal of Managed Care | 13 hours ago

    A survey has revealed gaps in HIV providers’ knowledge of the Affordable Care Act. However, despite these gaps, the majority of surveyed providers expressed belief that Medicaid expansion would improve both HIV outcomes and general outcomes for patients with the disease.

  • New and experimental HIV treatments
    European advisory group backs Merck's HIV meds Delstrigo and Pifeltro
    Seeking Alpha | 13 hours ago

    The European Medicines Agency's advisory group CHMP adopts a positive opinion backing approval for Merck's (NYSE:MRK) DELSTRIGO (doravirine, lamivudine and tenofovir disoproxil fumarate) and PIFELTRO (doravirine) for the treatment of adults with chronic HIV-1 infection.

  • Epidemiology
    HIV diagnoses hit seven year low: Australia’s annual HIV figures released today
    Kirby Institute press release | 13 hours ago

    There were 963 new HIV diagnoses in Australia in 2017, representing a 7% decline over five years, and the lowest number of new diagnoses in seven years. The reductions were greatest among gay and bisexual men, with a 15% reduction in the past year alone. In contrast, the number of new HIV diagnoses increased by 10% among heterosexuals over the past five years, and HIV diagnosis rates remain almost two times higher in Aboriginal and Torres Strait Islander populations.

  • PrEP
    My PrEP Story: P
    PrEPster | 17 hours ago

    How did P Masters remember to take his PrEP? Find out in his My PrEP Story blog along with why a sexual partners’ HIV status no longer matters to him. My PrEP Story is the personal voice of people who are using, or have used, PrEP. Find out more about their decisions to use PrEP, how they have navigated using PrEP, and their very own PrEP journey.

  • Transgender people
    My PrEP Story: KUCHENGA
    Prepster | 17 hours ago

    The majority of KUCHENGA’s sexual partners are straight. In her first My PrEP Story blog, KUCHENGA says it’s trans women who are educating straight men about PrEP. My PrEP Story is the personal voice of people who are using, or have used, PrEP. Find out more about their decisions to use PrEP, how they have navigated using PrEP, and their very own PrEP journey.

  • Employment
    Court Case Hoping to End Pentagon’s HIV Discharges Will Move Forward
    Poz | 17 hours ago

    The Trump administration had asked that the lawsuit be dismissed.

  • The search for a cure
    Investigators Uncover Details About A Rare Group of HIV Patients
    MD Magazine | 17 hours ago

    A pair of new studies is shedding light on a rare, but scientifically important, group of people with HIV who are able to maintain viral control even after stopping antiretroviral therapy. Clues about this ability may help improve antiretroviral therapy, which currently most patients with HIV must receive for life.

← First12345...12Next →

Conference news

News from the 22nd International AIDS Conference (AIDS 2018).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the August edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.